Plan for Testing Fingerstick Bloods on Magellan Systems

Plan for Testing Fingerstick Bloods on Magellan Systems

This study is to supplement our internal data that demonstrates the continued performance of capillary blood samples on Magellan's lead testing systems: LeadCare II, LeadCare Ultra (which have been cleared previously by FDA), and PediaStat, which is an upgraded LeadCare II instrument in development.

Inclusion Criteria:

• healthy subjects who consent to a capillary blood collection

Exclusion Criteria:

• Patients are not currently taking chelating agents, e.g., penicillamine, succimer